MindBio Therapeutics Statistics

Total Valuation

CSE:MBIO has a market cap or net worth of CAD 5.46 million. The enterprise value is 9.86 million.

Market Cap	5.46M
Enterprise Value	9.86M

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:MBIO has 546.20 million shares outstanding. The number of shares has decreased by -40.06% in one year.

Current Share Class	546.20M
Shares Outstanding	546.20M
Shares Change (YoY)	-40.06%
Shares Change (QoQ)	-0.46%
Owned by Insiders (%)	8.02%
Owned by Institutions (%)	n/a
Float	560.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-9.66
PB Ratio	-1.00
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.74
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio	0.01
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-364.90%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	18.50%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.71% in the last 52 weeks. The beta is 0.13, so CSE:MBIO's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-85.71%
50-Day Moving Average	0.01
200-Day Moving Average	0.02
Relative Strength Index (RSI)	44.79
Average Volume (20 Days)	239,072

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:MBIO had revenue of CAD -565,340 and -1.46 million in losses. Loss per share was -0.01.

Revenue	-565,340
Gross Profit	-565,340
Operating Income	-954,812
Pretax Income	-1.47M
Net Income	-1.46M
EBITDA	n/a
EBIT	-954,812
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 12,777 in cash and 4.46 million in debt, giving a net cash position of -4.45 million or -0.01 per share.

Cash & Cash Equivalents	12,777
Total Debt	4.46M
Net Cash	-4.45M
Net Cash Per Share	-0.01
Equity (Book Value)	-5.44M
Book Value Per Share	-0.03
Working Capital	-5.16M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-274,518
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	168.89%
Pretax Margin	259.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:MBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	40.06%
Shareholder Yield	n/a
Earnings Yield	-26.78%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:MBIO has an Altman Z-Score of -583.87 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-583.87
Piotroski F-Score	1